Revere Pharmaceuticals is a Boston-based startup leading the way in the development of new cancer treatments targeting Rac1 GTPase, an important target in the progression of different cancers. R-ketorolac, their lead candidate, is a first-in-class Rac1 inhibitor that shows both clinical and non-clinical evidence of efficacy in ovarian cancer.

Pharmaceutical

Revere Pharmaceuticals

Revere Pharmaceuticals' headquarters in Arlington, MA, United States

Robert Silverman

Nabil Uddin

Jedd Levine

Kollol Pal

Marc Lippman

Revere Pharmaceuticals' Leadership Team includes Jedd Levine and 2 others.

About

People (3)

Erik Goka

Jedd Levine

Robert Silverman

Jobs